56-12-2
56-12-2
Chemical Structure
γ-Aminobutyric acid
Synonym(s): 4-Aminobutyric acid
- CAS No.: 56-12-2
- Formula:C4H9NO2
- Molecular Weight:103.12
IUPAC Name: 4-aminobutanoic acid
InChIKey: BTCSSZJGUNDROE-UHFFFAOYSA-N
SMILES: O=C(O)CCCN
Biological Activity: γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors. γ-Aminobutyric acid shows calming effect by blocking specific signals of central nervous system[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
γ-Aminobutyric acid | 99.71% | γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors. γ-Aminobutyric acid shows calming effect by blocking specific signals of central nervous system. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid (Standard) | 99.93% | γ-Aminobutyric acid (Standard) is the analytical standard of γ-Aminobutyric acid. This product is intended for research and analytical applications. γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors. γ-Aminobutyric acid shows calming effect by blocking specific signals of central nervous system. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid-d2 | 99.95% | γ-Aminobutyric acid-d2 is the deuterium labeled γ-Aminobutyric acid. γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid-4,4-d2 | γ-Aminobutyric acid-4,4-d2 is the deuterium labeled γ-Aminobutyric acid. γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid-13C4 | 99.95% | γ-Aminobutyric acid-13C4 is the 13C-labeled γ-Aminobutyric acid. γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid-15N | 98.04% | γ-Aminobutyric acid-15N (4-Aminobutyric acid-15N) is the 15N-labeled γ-Aminobutyric acid (HY-N0067). γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors. γ-Aminobutyric acid shows calming effect by blocking specific signals of central nervous system. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
γ-Aminobutyric acid-d6 | 99.92% | γ-Aminobutyric acid-d6 is the deuterium labeled γ-Aminobutyric acid. γ-Aminobutyric acid (4-Aminobutyric acid) is a major inhibitory neurotransmitter in the adult mammalian brain, binding to the ionotropic GABA receptors (GABAA receptors) and metabotropic receptors (GABAB receptors). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Chen S, et al. Effects of dietary gamma-aminobutyric acid supplementation on the intestinal functions in weaning piglets. Food Funct. 2019 Jan 2. [Content Brief]
- [2]. Okada R, et al. Gamma-aminobutyric acid (GABA)-mediated neural connections in the Drosophila antennal lobe. J Comp Neurol. 2009 May 1;514(1):74-91. [Content Brief]
